Skip to main content

Year: 2023

Kforce Reports Third Quarter 2023 Revenue Of $373.1 Million; And Earnings Per Share Of $0.54, As Reported; As Adjusted For Certain Third Quarter Charges, Earnings Per Share Of $0.90

TAMPA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) — Kforce Inc. (Nasdaq: KFRC), a solutions firm that specializes in technology and other professional staffing services, today announced results for the third quarter of 2023. There are references to “as reported” and “as adjusted” figures within this press release, which pertain to GAAP and non-GAAP measures that are more fully described in the Adjusted Financial Performance Measures section of this press release. Joseph J. Liberatore, President and Chief Executive Officer, said, “The Firm continues to operate effectively against a challenging macro environment. We believe that our laser focus on growing our business organically with a consistent, refined business model tailored to provide highly skilled technology talent solutions to world-class companies continues to drive our success....

Continue reading

Monolithic Power Systems Announces Results for the Third Quarter Ended September 30, 2023

KIRKLAND, Wash., Oct. 30, 2023 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless company with a global footprint that provides high-performance, semiconductor-based power electronic solutions, today announced financial results for the quarter and nine months ended September 30, 2023. The financial results for the quarter ended September 30, 2023 were as follows:● Revenue was $474.9 million for the quarter ended September 30, 2023, a 7.6% increase from $441.1 million for the quarter ended June 30, 2023 and a 4.1% decrease from $495.4 million for the quarter ended September 30, 2022.   ● GAAP gross margin was 55.5% for the quarter ended September 30, 2023, compared with 58.7% for the quarter ended September 30, 2022.   ● Non-GAAP gross margin (1) was 55.7% for the quarter ended September...

Continue reading

Biomea Fusion Reports Third Quarter 2023 Financial Results and Corporate Highlights

Demonstrated durable HbA1c lowering in the escalation portion of ongoing Phase II study in type 2 diabetes (COVALENT-111), with 84% of all patients showing a reduction of HbA1c after 4 weeks dosing and 74% after another 8 weeks off-treatment period Expansion portion of COVALENT-111 cleared and actively enrolling in the U.S. and Canada; expected to enroll approximately 200 adults with type 2 diabetes Investigational new drug (IND) application cleared for Phase II clinical trial of BMF-219 in type 1 diabetes (COVALENT-112); enrollment of 150 adults with type 1 diabetes anticipated to begin in Q4 2023 Dosed first relapsed/refractory AML patient with BMF-500, Biomea’s novel third generation investigational oral covalent inhibitor of FMS-like tyrosine kinase 3 (FLT3) Reported initial topline data of BMF-219 in ongoing Phase I clinical trial...

Continue reading

1st Capital Bancorp Announces Third Quarter 2023 Financial Results

SALINAS, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — 1st Capital Bancorp (the “Company”), (OTCQX: FISB), the $984.1 million asset bank holding company and parent company of 1st Capital Bank (the “Bank”), today reported unaudited net income of $1.19 million for the quarter ended September 30, 2023, an increase of 96.2% compared to net income of $609 thousand for the quarter ended June 30, 2023, and a decrease of 55.1% compared to net income of $2.66 million for the quarter ended September 30, 2022. Deposit balances have increased $26.7 million, or 3.0%, in the quarter ended September 30, 2023 compared to June 30, 2023. Loan demand remained strong in the third quarter as the Company’s core loans increased $21.6 million, or 3.7%, at September 30, 2023 compared to June 30, 2023. This growth was partially offset by a $5.8 million decline...

Continue reading

Horizon Bank Announces Equipment Finance Division led by Joel Mikolich

MICHIGAN CITY, Ind., Oct. 30, 2023 (GLOBE NEWSWIRE) — Horizon Bank announced today the formation of a new equipment finance division to be led by Joel Mikolich as the division President. The new division will provide business equipment financing solutions to small and medium sized businesses nationwide, while enhancing Horizon’s depth of services to its existing clients providing for continued profitable growth in Horizon’s Commercial platform. Joel Mikolich is a seasoned veteran of the equipment finance industry with 20+ years of experience and a successful track record for leading banks into this strategic line of business. Throughout his career, Joel has provided innovative financing and developed successful teams that have assisted small and mid-sized companies obtain the funding and capital solutions necessary to fuel their...

Continue reading

Heidelberg Materials North America Acquires Bach & Co. Assets

Heidelberg Materials North America has acquired the aggregate assets of Bach & Co. in Clayton, New York. Irving, Texas, Oct. 30, 2023 (GLOBE NEWSWIRE) — Heidelberg Materials North America announced today that it has acquired the aggregate assets of Bach & Co. in New York. The assets include a sand & gravel site and additional high-quality reserves within the company’s existing Northern New York State footprint. “The acquisition of the Bach & Co. assets further strengthens our aggregates reserves in the Northern New York State area and fortifies our vertically integrated footprint in this key market,” said Alex Car, President of the Northeast Region for Heidelberg Materials North America.    This latest acquisition reflects the company’s strategic plan to optimize its portfolio in core markets and strengthen...

Continue reading

Vallourec launches an employee investment program

Vallourec launches an employee investment program Paris, 30 October 2023 – Vallourec, a world leader in premium steel tubular solutions announces today the launch of Vallourec Invest 2023 (the “Offer”), a share capital increase reserved for employees, as per the decision made on 27 July 2023, by the Board of Directors in accordance with the thirteenth and fourteenth resolutions of the Annual General Meeting of Shareholders on 25 May 2023. The Offer reflects Vallourec’s commitment to involve its employees in the Group’s value creation, by offering them the opportunity to invest in Vallourec’s future. Issuer Vallourec SA12 rue de la Verrerie 92190 – Meudon – FranceEuronext Paris Ordinary share ISIN code: FR0013506730Security eligible to the Deferred Settlement Service (Service de Règlement Différé or SRD) Purpose of the transaction – reason...

Continue reading

Nokia Corporation: Repurchase of own shares on 30.10.2023

                           STOCK EXCHANGE RELEASE              30 October 2023                         Nokia CorporationStock Exchange Release              30 October 2023 at 21:00 EET              Nokia Corporation: Repurchase of own shares on 30.10.2023                                                       Espoo, Finland – On 30 Oct 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:                                        Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*        AQEU ...

Continue reading

RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

Study Intends To Identify Hematology Biomarkers That May Help Personalize Medical Evaluations For Patients Undergoing Treatments For Wet Macular Degeneration PETALUMA, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced the launch of an Institutional Review Board (“IRB”) for research on its DNA/GPS program. The study aims to offer recommendations for enhancing the preselection process and management of ocular injections. The proposed patient selection process has the potential to reduce the cost and improve the safety and efficacy of patient candidate selection for ocular injections. These factors represent significant challenges associated with wet macular degeneration-related vision loss. “RetinalGeniX DNA/GPS has submitted a study with...

Continue reading

Havila Kystruten AS: Havila Pollux out of operation due to technical issue

Havila Pollux yesterday interrupted her northbound trip in Trondheim due to technical error on an electric engine.  The engine needs to be replaced, which is expected to be arranged so that Havila Pollux can serve the coast again from 8 November. Passengers choose whether to continue their journey on one of the other ships or choose other compensation. Contacts CEO Bent Martini, +47 905 99 650 CFO Arne Johan Dale, +47 909 87 706

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.